Literature DB >> 21457135

Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.

Minh Hien Pham1, Hervé Rhinn, Nicolas Auzeil, Anne Regazzetti, Djamel Eddine Harami, Daniel Scherman, Guy G Chabot.   

Abstract

The metabolism of flavone-8-acetic acid (FAA) has been hypothesized to be partly responsible for its potent anticancer activity in mice. The purpose of this study was to identify the mouse enzymes involved in FAA Phase I metabolism and evaluate their possible induction in vivo by FAA. Mouse microsomes metabolized FAA into 6 metabolites: 3',4'-dihydrodiol-FAA, 5,6-epoxy-FAA, 4'-OH-FAA, 3'-OH-FAA, 3',4'-epoxy-FAA and 6-OH-FAA. Using Cyp-specific inhibitors (furafylline, Cyp1a2; α-naphthoflavone, Cyp1b1; tranylcypromine, Cyp2b9; quercetin, Cyp2c29; quinidine, 2d9; diethyldithiocarbamate, Cyp2e1; ketoconazole, Cyp3a11), the formation of 5,6-epoxy-FAA was mainly attributed to Cyps 1a2, 1b1, 2b9, 2c29 and 2e1, whereas the 3',4'-epoxy-FAA was formed by Cyps 2b9 and 3a11. The 4'-OH-FAA was generated by Cyps 1a2, 1b1, 2b9 and 2e1, and the 6-OH-FAA was formed by Cyps 1b1 and 2c9. Using the epoxide scavenger N-acetyl cysteine, 4'-OH-FAA, 3'-OH-FAA and 6-OH-FAA were shown to derive partly from non enzymatic isomerisation of their corresponding epoxides. The specific epoxide hydrolase inhibitor elaidamide allowed the confirmation that 3',4'-dihydrodiol-FAA was formed via the epoxide hydrolase. FAA treatment in vivo in mice led to a significant increase in the hepatic expression of Cyp1a2 (1.9-fold), 2e1 (2.1-fold), 2b10 (3.2-fold), 2d9 (2.3-fold) and 3a11 (2.2-fold), as evaluated by qRT-PCR. In conclusion, several Cyps were shown to be involved in FAA metabolism, particularly Cyps 3a11 and 2b9 which were responsible for the formation of the principal metabolites (5,6-epoxy-FAA, 3',4'-epoxy-FAA), and that FAA could induce the expression of several Cyps after in vivo administration. The possible implication of these enzymes in the in vivo anticancer activity of FAA in mice is discussed. ©2011 Bentham Science Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21457135      PMCID: PMC3743746          DOI: 10.2174/187231211795305221

Source DB:  PubMed          Journal:  Drug Metab Lett        ISSN: 1872-3128


  45 in total

Review 1.  Cytochrome P450 oxidations in the generation of reactive electrophiles: epoxidation and related reactions.

Authors:  F Peter Guengerich
Journal:  Arch Biochem Biophys       Date:  2003-01-01       Impact factor: 4.013

2.  One-step quantification of single-stranded DNA in the presence of RNA using Oligreen in a real-time polymerase chain reaction thermocycler.

Authors:  Hervé Rhinn; Daniel Scherman; Virginie Escriou
Journal:  Anal Biochem       Date:  2007-08-23       Impact factor: 3.365

Review 3.  Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450.

Authors:  Petr Hodek; Pavel Trefil; Marie Stiborová
Journal:  Chem Biol Interact       Date:  2002-01-22       Impact factor: 5.192

4.  Use of a novel real-time quantitative reverse transcription-polymerase chain reaction method to study the effects of cytokines on cytochrome P450 mRNA expression in mouse liver.

Authors:  J Pan; Q Xiang; S Ball
Journal:  Drug Metab Dispos       Date:  2000-06       Impact factor: 3.922

5.  Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man.

Authors:  J J Bogaards; M Bertrand; P Jackson; M J Oudshoorn; R J Weaver; P J van Bladeren; B Walther
Journal:  Xenobiotica       Date:  2000-12       Impact factor: 1.908

6.  Inhibition of microsomal epoxide hydrolases by ureas, amides, and amines.

Authors:  C Morisseau; J W Newman; D L Dowdy; M H Goodrow; B D Hammock
Journal:  Chem Res Toxicol       Date:  2001-04       Impact factor: 3.739

Review 7.  Flavonoids as anticancer agents: structure-activity relationship study.

Authors:  M López-Lázaro
Journal:  Curr Med Chem Anticancer Agents       Date:  2002-11

8.  In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids.

Authors:  V M Breinholt; E A Offord; C Brouwer; S E Nielsen; K Brøsen; T Friedberg
Journal:  Food Chem Toxicol       Date:  2002-05       Impact factor: 6.023

9.  Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.

Authors:  Brigitte Bauvois; Marie-Line Puiffe; Jean-Bernard Bongui; Sandrine Paillat; Claude Monneret; Daniel Dauzonne
Journal:  J Med Chem       Date:  2003-08-28       Impact factor: 7.446

Review 10.  Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

Authors:  David R Nelson; Darryl C Zeldin; Susan M G Hoffman; Lois J Maltais; Hester M Wain; Daniel W Nebert
Journal:  Pharmacogenetics       Date:  2004-01
View more
  1 in total

1.  Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice.

Authors:  Chad N Brocker; Daxesh P Patel; Thomas J Velenosi; Donghwan Kim; Tingting Yan; Jiang Yue; Guolin Li; Kristopher W Krausz; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2018-08-29       Impact factor: 5.922

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.